SEC Form S-4 filed by CHP Merger Corp.

PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) -- Integrity Implants Inc. d/b/a Accelus ("Accelus"), a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, and CHP Merger Corp. ("CHP") (NASDAQ:CHPM, CHPMU and CHPMW))), a special purpose acquisition company (SPAC), announced today that the companies have mutually agreed to terminate, effective immediately, the previously announced business combination agreement dated November 14, 2021 as a result of market conditions. "In light of market conditions, we believe that this strategic pivot will best enable our team to exe

SUMMIT, N.J., Nov. 24, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it held a special meeting of stockholders (the "Special Meeting") relating to the proposal (the "Extension Proposal") to amend the Company's amended and restated certificate of incorporation to extend the date by which the Company must complete its initial business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S. based medical technology company focused on the spinal surgery market (the "Accelus Business Combination") from November 26, 2021 to May 26, 2022 (the "Extension"), which the stockholders voted to approve. The Extension Proposal is described in fu

SUMMIT, N.J., Nov. 22, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it convened and then adjourned, without conducting any other business, the Company's special meeting of stockholders (the "Special Meeting") held on November 22, 2021. The Special Meeting has been adjourned until November 24, 2021 at 9:00 a.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to vote on the proposal to extend the date by which the Company must consummate the previously announced business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S.-based medical technology company focused on the spinal surgery market (the "Accelus Bus

4 - CHP Merger Corp. (0001785041) (Issuer)

3 - CHP Merger Corp. (0001785041) (Issuer)

15-12B - CHP Merger Corp. (0001785041) (Filer)

RW - CHP Merger Corp. (0001785041) (Filer)

25-NSE - CHP Merger Corp. (0001785041) (Subject)

SC 13G/A - CHP Merger Corp. (0001785041) (Subject)

SC 13G/A - CHP Merger Corp. (0001785041) (Subject)

SC 13G/A - CHP Merger Corp. (0001785041) (Subject)